Microwave ablation: Clinical Trials

10 trials of Microwave ablation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 3 unknown, 2 not yet recruiting, 1 completed. 10 Phase 2, 2 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 210Recruiting 3, Unknown 3, Not yet recruiting 2, Completed 1, Terminated 1
Phase 32Not yet recruiting 1, Unknown 1
Phase 11Unknown 1

Follow Microwave ablation: new trials by email Literature Review of Microwave ablation trials Research Report on Microwave ablation

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Injection of IP-001 Into Thermally Ablated Hepatic Tumors in Patients With Colorectal Liver Metastases
1.0% IP-001 for Injection, a 10 mg/mL solution of IP-001 in water, 1.0% IP-001 for Injection, a 1 mg/mL solution of IP-001 in water., Microwave (thermal) tumor ablation - Colorectal Cancer (CRC), Colon Cancer Liver Metastases
Phase 2 / Phase 3Not yet recruitingImmunophotonics, Inc.7172026-05-012026-01-07
Microwave Ablation Plus Tislelizumab and Docetaxel in Advanced NSCLC After First-Line Immunotherapy Failure
Tislelizumab, Docetaxel, Microwave ablation - NSCLC (Non-small Cell Lung Cancer), NSCLC (Advanced Non-small Cell Lung Cancer)
Phase 2RecruitingTianjin Medical University Cancer Institute and Hospital202026-05-012026-04-14
A Study of Microwave Ablation Combined With Immunotherapy ± Anti-angiogenic Drugs in the Treatment of Solid Tumors
Adebrelimab, Apatinib, microwave ablation - Solid Tumor
Phase 2Not yet recruitingBeidahuang Industry Group General Hospital602024-08-052024-08-05
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Stereotactic Ablative Radiotherapy, Resection, Microwave Ablation - Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8
Phase 2RecruitingAlliance for Clinical Trials in Oncology1462023-10-092026-11-03
Almonertinib Plus Microwave Ablation in Advanced Non-small Cell Lung Cancer
Almonertinib plus microwave ablation - Advanced Non Small Cell Lung Cancer
Phase 2UnknownQianfoshan Hospital2342022-01-012021-09-05
Microwave Ablation Combined With Camrelizumab in the Treatment of Early Breast Cancer
Microwave Ablation, Camrelizumab, Breast Surgery - Breast Cancer
Phase 2CompletedThe First Affiliated Hospital with Nanjing Medical University602021-03-252024-01-05
Efficiency and Safety of Microwave Ablation Plus Immune Checkpoint Inhibitor for Patients With Multiple Primary Lung Cancer: A Open, Multi-center, Phase II Clinical Trial
Microwave ablation plus Camrelizumab, Microwave ablation - Multiple Primary Lung Cancer
Phase 2RecruitingShanghai Pulmonary Hospital, Shanghai, China1462021-03-212021-09-23
Microwave Ablation of Primary and Secondary Lung Malignancies
Microwave ablation - Lung Neoplasms, Neoplasm Metastasis
Phase 1 / Phase 2UnknownUniversity of Calgary352020-05-012020-11-09
Cryoablation, Radiofrequency Ablation, or Microwave Ablation in Treating Patients With Metastatic Sarcoma Stable on Chemotherapy
Microwave ablation, Cryoablation, Radiofrequency ablation - Osteosarcoma, Sarcoma
Phase 2TerminatedWashington University School of Medicine92014-02-032018-09-19
Ultrasound Guided Percutaneous Microwave Ablation for Breast Lesions
microwave ablation - Neoplasm of Breast
Phase 2 / Phase 3UnknownChinese PLA General Hospital5002012-12-012016-11-23

Conditions studied

Breast Neoplasms (2)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Colorectal Neoplasms (2)  ·  Neoplasm Metastasis (2)  ·  Lung Neoplasms (1)  ·  Neoplasms (1)  ·  Osteosarcoma (1)  ·  Rectal Neoplasms (1)  ·  Sarcoma (1)

Sponsors

Alliance for Clinical Trials in Oncology (1)  ·  Beidahuang Industry Group General Hospital (1)  ·  Chinese PLA General Hospital (1)  ·  Immunophotonics, Inc. (1)  ·  Qianfoshan Hospital (1)  ·  Shanghai Pulmonary Hospital, Shanghai, China (1)  ·  The First Affiliated Hospital with Nanjing Medical University (1)  ·  Tianjin Medical University Cancer Institute and Hospital (1)  ·  University of Calgary (1)  ·  Washington University School of Medicine (1)

Countries

China (5)  ·  Canada (2)  ·  United States (2)

Top investigators

Brian Van Tine, M.D., Ph.D. (1)  ·  Chang Chen, Dr (1)  ·  Diane M Beatty, PhD (1)  ·  Ping Liang, Doctor (1)  ·  Stefan J Przybojewski, MB ChB (1)

Results publications

PMID 29487221, PMID 31179781, PMID 32356159, PMID 36652155, PMID 38350888, PMID 38417440

NIH funding

2025 (1)